|
| ID |
DDInter1329 |
| Drug Type |
small molecule |
| Molecular Formula |
C22H30N2O2S |
| Molecular Weight |
386.560
|
| Description |
Oliceridine is a biased opioid agonist indicated for the management of severe acute pain in adult patients. Through preferential activation of G-protein-coupled signalling pathways, oliceridine provides analgesic effect with a comparable or improved safety profile over conventional opioid agonists.
|
| ATC Classification |
- |
| IUPAC Name |
[(3-Methoxythiophen-2-Yl)Methyl]({2-[(9R)-9-(Pyridin-2-Yl)-6-Oxaspiro[4.5]Decan-9-Yl]Ethyl})Amine |
| InChI |
Inchi=1S/C22H30N2O2S/C1-25-18-7-15-27-19(18)16-23-13-10-21(20-6-2-5-12-24-20)11-14-26-22(17-21)8-3-4-9-22/H2,5-7,12,15,23H,3-4,8-11,13-14,16-17H2,1H3/T21-/M1/S1 |
| InChI Key |
DMNOVGJWPASQDL-OAQYLSRUSA-N |
| Canonical SMILES |
COC1=C(CNCC[C@]2(CCOC3(CCCC3)C2)C2=NC=CC=C2)SC=C1 |
| Useful Links |
DrugBank
ChEMBL
|